The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Erythrodermic Psoriasis Management

Severe life-threatening psoriasis variant with generalized erythema and scaling involving >75-90% body surface area, complicated by impaired thermoregulation, fluid loss, secondary infections, and high-output cardiac failure requiring urgent dermatologic and critical care.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Erythrodermic Psoriasis Management?

Erythrodermic psoriasis is the most severe life-threatening variant of psoriasis characterized by generalized erythema and exfoliative scaling involving >75-90% of body surface area with potential systemic complications.

Pathophysiology involves massive cytokine release (TNF-α, IL-17, IL-23, IL-22) causing widespread skin inflammation, increased vascular permeability, capillary leak, and metabolic derangements. Loss of skin barrier leads to fluid loss, hypothermia, and increased infection risk.

Triggers include withdrawal of systemic corticosteroids, severe sunburn, infections (HIV, streptococcal), medications (lithium, beta-blockers, antimalarials, terbinafine), excessive alcohol, and progression from chronic plaque psoriasis. Mortality 4-64% if untreated due to sepsis, hypothermia, or cardiac failure.

Symptoms

Generalized red skin involvement >75-90% body surface
Diffuse scaling with sheets of desquamation
Edema and warmth of affected skin
Severe pruritus and burning sensation
Chills, fever, and rigors from impaired thermoregulation
Tachycardia and hemodynamic changes
Lymphadenopathy and palmoplantar involvement
Hair loss and onychodystrophy

Risk Factors

Pre-existing chronic plaque psoriasis (most common)
Abrupt withdrawal of systemic corticosteroids
Drug-induced: lithium, antimalarials, beta-blockers, terbinafine
Severe sunburn or phototherapy overdose
Severe systemic infection or HIV
Excessive alcohol consumption
Generalized contact dermatitis on existing psoriasis
Pustular psoriasis transformation

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Generalized red scaling skin involving >75% of body
  • Hypothermia or hyperthermia with chills
  • Tachycardia and hemodynamic instability
  • Hospital admission criteria: dehydration, electrolyte imbalance, secondary infection
  • Rapid skin progression in known psoriasis patient
  • Symptoms of high-output cardiac failure
  • Critical care evaluation for severe disease

Treatment Methods

01
Hospital admission to dermatology or burn unit for monitoring and supportive care
02
Supportive: warming blanket, IV fluid resuscitation (often 4-6 L/day), electrolyte correction
03
Skin care: bland emollients (white petrolatum) every 2-4 hours, soft cotton dressings, low-potency topical corticosteroids
04
Nutritional support: high-protein diet (1.5-2 g/kg/day), albumin replacement if hypoalbuminemia
05
Infection prophylaxis and treatment: blood cultures, empiric antibiotics if signs of sepsis
06
First-line systemic: cyclosporine 3-5 mg/kg/day (rapid onset 1-2 weeks)
07
Second-line: infliximab 5 mg/kg IV at week 0, 2, 6 (rapid response)
08
IL-17 inhibitors: ixekizumab, secukinumab, brodalumab for refractory cases
09
IL-23 inhibitors: guselkumab, risankizumab for maintenance
10
Avoid systemic corticosteroids (rebound and pustular flare risk)
11
Long-term maintenance with biologic therapy after stabilization

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.